FDA digital health leader promises generative AI regulatory guidance is coming
admin The pivot toward a "competency-based approach" represents a fundamental reimagining of how the federal government...
Health
The Clinical Bottleneck: Why a Severe Shortage of Mentors is Stalling the Next Generation of Nurse Practitioners
In the heart of Chicago, midway through an intensive graduate nursing program, Yesenia Raithel Vargas...
The Power of a Handshake: Restoring Human Connection in the High-Tech Era of Emergency Medicine
During a recent shift in the emergency department, Zain Khawaja, M.D., an emergency medicine resident...
FDA plans to regulate generative AI
The most seismic shift currently underway concerns the national approach to immunization. Following President Trump’s...
Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more
The cornerstone of the administration’s pharmaceutical platform was a highly publicized pledge to make high-priced...
Public-sector purgatory, and a union-hospital fight
The scale of the impending crisis was brought into sharp focus by a recent report...
Lady Gaga and her fiancé launch a biotech startup
The FTC’s recent move to challenge Amgen’s patent strategy marks a significant escalation in the...
The Healing Gap: How Retired Doctors and Community Clinics Can Bridge America’s Healthcare Divide
After nearly four decades navigating the complex corridors of clinical medicine, I stepped into retirement...
FDA pauses Regenxbio gene therapy trial again due to safety concerns
The clinical hold specifically impacts the development of RGX-121, an investigational gene therapy designed to...
Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection
The crux of the controversy lies in Capricor’s recent announcement that it intends to use...
